Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
09/2006
09/20/2006EP1702918A2 Process for the preparation of Bis-DMTD (5,5-dithio-bis-(1,3,4-thiadiazol-2-thiole))
09/20/2006EP1549624A4 Inhibitors of fatty acid amide hydrolase
09/20/2006EP1204651B1 Herbicidal 5-chlorodifluoromethyl-1,3,4-thiadiazol-2-yl-oxyacetanilides
09/19/2006US7109364 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups
09/19/2006US7108948 Organophotoreceptor with charge transport compositions
09/14/2006WO2006040113A3 Heterocyclic diamide insecticidal agents
09/13/2006EP1699766A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors
09/13/2006EP1246617B1 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of ovarian cancer
09/13/2006CN1832944A Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
09/13/2006CN1274679C Method for production of particle-contg. prepn. of tetrahydro-3, 5-dimethyl-1,3,5-thiadiazin-2-thione
09/13/2006CN1274678C New benzothiazine and benzothiadiazine compounds,its preparation process and pharmaceutical composition containing said compounds
09/13/2006CN1274670C Diaminopropionic acid derivatives
09/12/2006US7105665 Compound for treatment of diarrhea, nervous system disorders such as Alzheimers and asthma in mammals
09/12/2006US7105520 Alpha 4 integrin antagonists
09/08/2006WO2006093801A1 Thiadiazine derivatives useful as anti-infective agents
09/08/2006WO2006068821A3 Processes for the preparation of 3,4-substituted-1,2,5-thiadiazoles and intermediates thereof
09/08/2006WO2006055542A3 Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
09/06/2006EP1697333A1 (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists
09/06/2006EP1697302A1 Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders
09/06/2006CN1829704A Benzo [1,2,5] thiadiazole compounds as CCK2 modulators
09/06/2006CN1829513A 5-membered heterocycle-based p-38 inhibitors
09/06/2006CN1827609A Process for the preparation of bis-dmtd (5,5-dithio-bis-(1,3,4-thiadiazol-2-thiole))
09/06/2006CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
09/05/2006USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent
09/05/2006US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
08/2006
08/31/2006WO2004087053A3 Dipeptidyl peptidase inhibitors
08/30/2006EP1695705A1 Compounds effecting glucokinase
08/30/2006EP1694659A1 Thiadiazoles as cxc- and cc- chemokine receptor ligands
08/30/2006EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
08/30/2006CN1826310A Novel aminobenzophenone compounds
08/29/2006US7098325 For solid phase synthesis of phosphorothioate-containing antisense oligonucleotides; gene expression inhibition
08/24/2006US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
08/23/2006EP1692124A1 Biaryl sulfonamides as mmp inhibitors
08/23/2006EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same
08/22/2006US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists
08/22/2006US7094902 Electroactive polymers
08/22/2006US7094807 Viricides; hepatitis virus
08/17/2006WO2006085108A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia
08/17/2006WO2006084934A1 Use of thiadiazolidine-derived compounds as neurogenic agents
08/17/2006WO2006084854A2 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
08/17/2006WO2005107762A3 Certain chemical entities, compositions, and methods
08/17/2006US20060183783 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc.
08/17/2006CA2597523A1 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated withcytotoxicity in general and apoptosis in particular
08/16/2006EP1689493A1 Calcitonin gene related peptide receptor antagonists
08/16/2006EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
08/16/2006EP1087941B1 Thiolesters and uses thereof
08/15/2006US7091247 urotensin antagonists; vasoactive agents
08/15/2006US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics
08/15/2006CA2168193C Aryalkyl-thiadiazinones
08/10/2006WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/10/2006US20060177750 organophotoreceptor
08/10/2006DE102005004472A1 Verfahren zur Herstellung von Bis-DMTD A process for the preparation of bis-DMTD
08/10/2006CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/09/2006EP1688041A1 An agricultural and horticultural disease controller and a method for controlling the diseases
08/08/2006US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis
08/08/2006US7087621 Benzo- and azabenzodithiazole compounds
08/08/2006US7087611 Reacting ziprasidone with hydrochloric acid in solvent; salt formation; drying
08/08/2006US7087598 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
08/08/2006CA2289512C 1,2,3-thiadiazole derivatives, plant disease controller and method for using the same
08/03/2006WO2006064375A9 Aminoaryl substituted five-membered ring heterocyclic compounds for the treatment of diseases
08/03/2006US20060173054 Treating Alzheimer's disease; e.g. 2',3',4',5,5',6,7,8,9,10-Decahydro-2-(5-(4-fluorophenyl)-1-methyl-pyrazol-3-yl)-5'-(2,2,2-trifluoroethyl)-spiro(6,9-methanobenzocyclooctene-11,3'-(1,2,5)thiadiazole)-1',1'-dioxide
08/03/2006CA2592116A1 Anti-inflammatory medicaments
08/02/2006EP1685094A1 Acylurea connected and sulfonylurea connected hydroxamates
08/02/2006EP1684752A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists
08/02/2006EP1684745A2 Hepatitis c virus inhibitors
08/02/2006CN1812966A N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides
08/02/2006CN1810808A New [1,2,3]-thiobiazole derivative and its synthesis and use
08/01/2006US7083656 safe from toxicological and dermatological points of view and make it possible to achieve dyeings of the desired intensity; have a good light fastness, acid fastness, crocking resistance and good stability when washed.
08/01/2006CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/2006
07/31/2006CA2534599A1 Process for the production of bis-dmtd
07/27/2006WO2006034315A3 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
07/27/2006US20060167266 1,2,4- thiadiazole compounds and use thereof
07/27/2006US20060167065 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
07/27/2006US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
07/27/2006US20060166990 Novel aminobenzophenone compounds
07/26/2006CN1809542A Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof.
07/25/2006CA2278429C Pesticidal thiadiazines
07/19/2006EP1444215B1 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
07/18/2006US7078565 Benzamide derivatives as antagonists of orexin receptors
07/18/2006US7078418 e.g., 2,6-bis(1-aziridino-1-hydroxyiminomethyl)pyridine; treating colon, stomach, lung, breast and uterus cancer
07/18/2006CA2190727C Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
07/13/2006WO2006072436A1 [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
07/13/2006WO2006002088A3 Amino-quinazoline derivatives as antitumor agents
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006CA2593463A1 [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
07/12/2006EP1679303A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative
07/12/2006EP1678142A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
07/12/2006EP1678123A1 Tetrahydro-naphthalene and urea derivatives
07/12/2006CN1802361A M-stage kinesin inhibitor
07/11/2006US7074788 Antidiabetic agents; liver disorders; cardiovascular disorders; dietetics
07/11/2006US7074776 Exposing bacterium to heterocyclic comound for controlling growth
07/11/2006US7074532 Linked dihydrazone-based charge transport compounds
07/06/2006WO2006069685A1 Substituted oxyarenes
07/06/2006US20060148864 Treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders
07/06/2006US20060148863 E.g., 3-[5-(2-Chloro-pyridin-3-yl)-[1,2,4]oxadiazol-3-yl]-benzoic acid; treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders
07/06/2006US20060148861 For treatment of psychotic disorders including schizophrenia, anxiety, depression and bipolar disorders; neurodegenerative diseases, epilepsy and pain including headaches and migraines
07/05/2006EP1676855A2 Prenyl transferase inhibitors
07/05/2006EP1675837A2 Benzo [1,2,5] thiadiazole compounds as cck2 modulators
07/05/2006CN1798742A Novel biaromatic compounds which activate ppar [upsilon] pharmaceutical compsns
06/2006
06/29/2006US20060141395 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 100